(ST095) Impact of tumor percentage on tumor mutational burden and microsatellite instability measurements from a comprehensive genomic profiling sequencing panel

Saturday, November 18, 2023

9:15 AM – 10:15 AM MST

Speaker(s)

Ken Hampel, PhD

Technical Director, Genomic Medicine
University of Vermont Medical Center
Burlington, Vermont, United States